The Role of Macrophages in Demyelinating Peripheral Nervous System of Mice Heterozygously Deficient in P0 by Carenini, Stefano et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2001/01/301/8 $5.00
The Journal of Cell Biology, Volume 152, Number 2, January 22, 2001 301–308
http://www.jcb.org/cgi/content/full/152/2/301 301
 
The Role of Macrophages in Demyelinating Peripheral Nervous System 
of Mice Heterozygously Deficient in P0
 
Stefano Carenini,* Mathias Mäurer,* Alexander Werner,
 
‡
 
 Heinrich Blazyca,* Klaus V. Toyka,*
Christoph D. Schmid,* Gennadij Raivich,
 
‡
 
 and Rudolf Martini*
 
*Department of Neurology, Section of Developmental Neurobiology, University of Würzburg, D-97080 Würzburg,
 
 
 
Germany; 
 
‡
 
Department of Neuromorphology, Max-Planck-Institute for Neuroscience, Martinsried, D-82152 Germany
 
Abstract. 
 
Mice heterozygously deﬁcient in the p0 gene
 
(P0
 
1
 
/
 
2
 
) are animal models for some forms of inherited
neuropathies. They display a progressive demyelinating
phenotype in motor nerves, accompanied by mild inﬁl-
tration of lymphocytes and increase in macrophages.
We have shown previously that the T lymphocytes are
instrumental in the demyelination process. This study
addresses the functional role of the macrophage in this
monogenic myelin disorder.
In motor nerves of P0
 
1
 
/
 
2
 
 mice, the number of mac-
rophages in demyelinated peripheral nerves was in-
creased by a factor of ﬁve when compared with motor
nerves of wild-type mice. Immunoelectron microscopy,
using a speciﬁc marker for mouse macrophages, dis-
played macrophages not only in the endoneurium of
the myelin mutants, but also within endoneurial tubes,
suggesting an active role in demyelination. To elucidate
the roles of the macrophages, we crossbred the myelin
mutants with a spontaneous mouse mutant deﬁcient in
macrophage colony-stimulating factor (M-CSF), hence
displaying impaired macrophage activation. In the P0-
deﬁcient double mutants also deﬁcient in M-CSF, the
numbers of macrophages were not elevated in the de-
myelinating motor nerves and demyelination was less
severe. These ﬁndings demonstrate an active role of
macrophages during pathogenesis of inherited demy-
elination with putative impact on future treatment
strategies.
Key words: macrophage • macrophage colony-stimu-
lating factor • myelin degeneration • Schwann cell • in-
herited neuropathies
 
Introduction
 
Inherited neuropathies are chronic disorders of the periph-
eral nervous system with a prevalence of 1:2,500 (Skre,
 
1974) including Charcot-Marie-Tooth disease (CMT),
 
1
 
 he-
reditary neuropathy with liability to pressure palsies, De-
jerine-Sottas syndrome, and congenital hypomyelination.
The majority of CMT patients suffer from a demyelinating
neuropathy with juvenile or adult onset. There are now
seven identified genes with various mutations associated
with the family of CMT-like disorders. Historically, the
peripheral myelin protein 22 gene was the first identified
as the culprit gene for CMT1A (Suter and Snipes, 1995);
and myotubularin-related protein-2, N-myc downstream-
regulated gene 1, and neurofilament-light are the most re-
cently discovered genes related to CMT4C, hereditary mo-
tor and sensory neuropathy-Lom, and to a distinct variant
of CMT2, respectively (Bolino et al., 2000; Kalaydjieva et
al., 2000; Mersiyanova et al., 2000). The remaining genes
related to CMT-like disorders encode the gap-junction
protein connexin 32, the transcription factor designated
early growth response 2 gene, and the cell adhesion mole-
cule P0 (for reviews see Nelis et al., 1999; Martini, 2000). A
good model for some CMT-like disorders are mice heterozy-
gously deficient in the p0 gene. We have shown recently that
in this model immune cells are involved in demyelination that
is primarily caused by an abnormal dosage of P0. The experi-
mental proof that lymphocytes are not only innocent by-
standers, but functionally involved in demyelination was
 
provided by crossbreeding P0 mutants (P0
 
1
 
/
 
2
 
) with mice
deficient in recombination activating gene-1 that lack ma-
ture T and B lymphocytes. These double mutants showed
a clear amelioration of the neuropathological changes in
peripheral nerves and of nerve conduction properties
compared with P0 mutants having wild-type T lympho-
cytes (Schmid et al., 2000). The same effect was observed
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op/op
 
, osteopetrotic; P0
 
1
 
/
 
2
 
, P0 mutant. 
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in mice deficient in the 
 
a
 
-subunit of the T cell receptor, re-
flecting a selective involvement of T cells in the pathogen-
esis of this inherited demyelinating disease (Schmid et al.,
2000). Based on these observations, we proposed that a
secondary immunopathological mechanism may contrib-
ute to nerve pathology (Schmid et al., 2000).
In the present study, we focussed on the potential patho-
genic impact of macrophages in inherited neuropathies.
We demonstrate that in the animal models macrophages
are present in a pattern reminiscent of chronic human and
experimental inflammatory neuropathies (Schmidt et al.,
1996; Ho et al., 1998; Gold et al., 1999). Moreover, myelin
mutants with an additional defect in microglia/macro-
phage activation show less nerve pathology than P0
 
1
 
/
 
2
 
mice with an intact macrophage system. These findings are
potentially important in the context of the understanding
of pathomechanisms in hereditary neuropathies and de-
signing disease modifying treatments.
 
Materials and Methods
 
Animals and Determination of Genotypes
 
P0
 
1
 
/
 
2
 
 
 
mice backcrossed to the C57/Bl6 background have been taken from
our own breeding colony (Schmid et al., 2000). 
 
Osteopetrosis 
 
is a sponta-
neous autosomal recessive mutation with the homozygous mice (
 
op/op
 
)
lacking biologically active M-CSF due to a single base insertion (T), creat-
ing a premature stop codon (Yoshida et al., 1990). Lack of incisor tooth
eruption is the most definitive phenotypic marker of the 
 
op/op
 
 genotype.
The heterozygous 
 
op/wt
 
 mice are phenotypically normal and these mice
were maintained as a breeding colony on a mixed C57/Bl6/C3 background.
Double mutants were obtained by crossing 
 
op/wt
 
 with P0
 
1
 
/
 
2
 
 mice, leading
to 
 
z
 
25% of the F1 progeny with the P0
 
1
 
/
 
2
 
 
 
op/wt
 
 genotype. Phenotypically
normal 
 
op/wt
 
, wt/wt, and osteopetrotic (
 
op/op
 
) animals with P0
 
1
 
/
 
2
 
 geno-
type (P0
 
1
 
/
 
2
 
 
 
op/op
 
) and normal P0
 
1
 
/
 
1
 
 were the F2 product of the double
heterozygous mice and were investigated at the age of 6 mo. Later stages
have not been investigated, since 
 
op/op
 
 mice often die at a premature age.
To avoid effects of the different genetic backgrounds, only littermates
were analyzed.
Genotypes of P0 mutants were determined by conventional PCR as de-
scribed (Schmid et al., 2000). Mice of the 
 
op/op
 
 genotype were deter-
mined by their typical absence of incisivi (Yoshida et al., 1990) and by a
PCR protocol generously provided by Dr. S. Oehen (University of Zürich,
Zürich, Switzerland).
 
 
 
Since 
 
op/wt
 
 mice display a normal phenotype and
behavior, their genotype had to be determined. The presence of wild-type
and mutant allele was detected by using oligonucleotides 5
 
9
 
-TGTGTC-
CCTTCCTCAGATTACA-3
 
9
 
 and 5
 
9
 
-GGTCTCATCTATTATGTCTTG-
TACCAGCCAAAA-3
 
9
 
, which introduce an additional BglI restriction
site into the mutant allele. The PCR was performed in a final volume of 20
 
m
 
l; 300 ng genomic DNA was used as template. The reaction product was
denaturated at 95
 
8
 
C for 3 min, followed by 5 cycles (94
 
8
 
C, 1 min; 56
 
8
 
C, 45 s;
72
 
8
 
C, 45 s), 35 cycles (94
 
8
 
C, 30 s; 52
 
8
 
C, 30 s; 72
 
8
 
C, 30 s), and a final exten-
sion at 72
 
8
 
C for 10 min with a PE Biosystems thermal cycler. The PCR
product was digested with BglI (20 IU; Boehringer) for 1 h at 37
 
8
 
C. After
digestion, the characteristic fragments indicating the genotypes could be
detected on a polyacrylamide gel by autoradiography. The wild-type was
represented by a 99- and 96-bp fragment, 
 
op/wt
 
 mice by a 99-, 96-, 70-, and
30-bp fragment, and 
 
op/op
 
-mice by a 96-, 70-, and 30-bp fragment.
 
Immunohistochemistry and
Immunoelectron Microscopy
 
For histological analyses, we have chosen the two major branches of the
femoral nerve, the quadriceps muscle nerve, and the cutaneous saphenous
nerve of the mouse. In some experiments, sciatic nerves have been investi-
gated at the level of the sciatic notch. In addition, we investigated the spi-
nal roots of the third and fourth lumbar segment.
For detection and quantification of T lymphocytes, antibodies to CD8
(a gift from R. Zinkernagel, University of Zürich, Zürich, Switzerland)
have been used on serial nerve cryosections as described previously
(Schmid et al., 2000).
 
For detection of macrophages, antibodies to mouse F4/80 (1:300; Sero-
tec) were applied overnight on 14-
 
m
 
m-thick serial sections from fresh fro-
zen femoral nerves and spinal roots. To visualize primary antibodies, a
biotinylated secondary antibody to rat Igs was applied for 1 h, followed by
avidin/biotin reagent (Dako) and staining with diaminobenzidine-HCl
and H
 
2
 
O
 
2
 
. For negative control, the primary antibody was omitted. In
femoral nerves, immunoreactive profiles were counted on serial cryosec-
tions as described (Schmid et al., 2000). In addition, immunolabeling of
single fiber preparations of
 
 
 
spinal roots from transcardially perfused mice
was performed on free-floating tissue as described (Guénard et al., 1996),
with the only modification that primary antibodies were detected by bio-
tinylated secondary antibodies, followed by avidin/biotin reagent as indi-
cated above. In some experiments, immunolabeled fibers were embedded
on slides and investigated under the light microscope. In other experi-
ments, the immunolabeled fibers were processed for electron microscopy
as described (Guénard et al., 1996).
For double immunofluorescence with the monoclonal rat antibodies to
mouse F4/80 and mouse major histocompatibility complex (MHC) class
II, fresh frozen sections of femoral nerves and spinal roots were first incu-
bated with the MHC class II antibodies (rat anti–mouse I-Ab, 1:400, 1 h;
BD PharMingen), followed by incubation with anti–rat Ig antibodies cou-
pled to FITC (1:200, 30 min; Leinco Technologies). Then, incubation with
a blocking reagent followed to avoid nonspecific binding of biotin/avidin
system reagents (Vector-Sp-2001, 30 min; Vector Laboratories). As a next
step, sections were incubated with a biotinylated F4/80 antibody (1:300, 1 h;
Serotec), which was visualized with streptavidin coupled to the red fluo-
rescent dye Cy3 (30 min; Dianova). Control experiments were performed
omitting primary antibodies, resulting in complete absence of immunore-
activity.
Double immunofluorescence with polyclonal antibodies to neural cell
adhesion molecule from rabbit (1:500; Carenini et al., 1999) and with mono-
clonal antibodies to mouse MHC class I (ER-HR 52, 1:100; Dianova)
from rat was performed by simultaneous incubation of primary antibodies
for 1.5 h, followed by simultaneous incubation of secondary antibodies
(goat anti–rabbit Cy3, 1:500; Dianova; goat anti–rat FITC, 1:500; Leinco
Technologies) for 1.5 h. Control experiments were performed omitting
primary antibodies resulting in complete absence of immunoreactivity.
For localizing M-CSF receptor expression, double immunofluorescence
using
 
 
 
rabbit anti–mouse
 
 
 
M-CSF receptor antibody (06-175, 1:5,000; UBI)
and the macrophage- and microglia-specific rat antibody to mouse 
 
a
 
M
 
b
 
2
integrin (5C6, 1:5,000; Serotec) has been performed as described (Raivich
et al., 1998), with the only exception that teased ventral root fibers instead
of free-floating brain sections have been used. Digital micrographs of the
FITC and Cy3 fluorescence were taken using a Leica TCS 4D confocal la-
ser microscope with a 63
 
3
 
 objective in an 8-bit greyscale (b/w), 1,024 
 
3
 
1,024 pixel format as described in previous studies (Raivich et al., 1998;
Kloss et al., 1999). 10 consecutive, equidistant levels spacing 12 
 
m
 
m were
recorded and condensed to a single bitmap using the MaxIntens algo-
rithm.
 
Tissue Preservation for Light and Conventional 
Electron Microscopy and Morphometry
 
Femoral nerves and spinal roots of mice were processed for light and elec-
tron microscopy as described previously (Schmid et al., 2000). Analysis of
the g-ratio (diameter of axons/diameter of fiber) of randomly selected
nerve fibers was performed on electron micrographs of the quadriceps
nerve and of the ventral roots at a final magnification of 1,600
 
3
 
 using
Scion Image Software (Scion Corp.).
 
Statistics
 
Statistical analysis was performed by using Student’s 
 
t
 
 test or Mann-Whitney
U test, when appropriate. 
 
P 
 
, 
 
0.05 was considered statistically significant.
 
Results
 
Immunohistochemistry and Quantification of F4/80- 
and 
 
a
 
M
 
b
 
2-positive Macrophages
 
In nerve cross sections of normal mice, the F4/80 immu-
noperoxidase-positive macrophages were usually ramified
or showed a few slender processes (Fig. 1, A and B). Most,
if not all, F4/80-immunoreactive macrophages in the quad- 
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riceps nerve and ventral root were MHC class II–positive,
as revealed by double immunofluorescence (not shown).
By contrast, MHC class I immunoreactivity was confined
to nonmyelinating Schwann cells, as revealed by double
immunofluorescence with antibodies to neural cell adhe-
sion molecule, recognizing nonmyelinating Schwann cells
in peripheral nerves (not shown).
Localization of the M-CSF receptor was performed
on teased fibers from ventral roots of 6-mo-old P0
 
1
 
/
 
1
 
and P0
 
1
 
/
 
2
 
 mice by double immunofluorescence using an
M-CSF receptor–specific antibody and the macrophage-
specific marker 
 
a
 
M
 
b
 
2. Labeling for M-CSF receptor was
exclusively associated with macrophages, whereas 
 
a
 
M
 
b
 
2-
negative cells, such as Schwann cells and endoneurial fi-
broblasts, were never labeled with antibodies to M-CSF
receptor (Fig. 2). Macrophages of the P0
 
1
 
/
 
1
 
 mice showed a
weak labeling for M-CSF receptor (Fig. 2). Interestingly,
P0
 
1
 
/
 
2
 
 mice showed some very strongly labeled macro-
phages in addition to weakly labeled macrophages (Fig. 2).
These data show that M-CSF receptor expression is con-
fined to macrophages and that expression levels are in-
creased in some macrophages of the P0
 
1
 
/
 
2
 
 mice.
Figure 1. (A and B) Immunhistological localization of macrophages in quadriceps nerves of P01/1 (A) and P01/2 mice (B) at the age of
6 mo using antibodies to F4/80. (A) In quadriceps nerves of P01/1 mice some resident macrophages are detectable in the endoneurium.
(B) In quadriceps nerves of P01/2 mice the number of macrophages is clearly elevated when compared with P01/1 mice. Note the larger
size of the cells and the close vicinity of two cells to an endoneurial blood vessel. (C) Quantification of F4/80-positive macrophages in
quadriceps and saphenous nerves of P01/1 (black bars) and P01/2 mice (gray bars) at the age of 2 (n 5 2 for P01/1 and P01/2), 6 (n 5 3
for P01/1; n 5 4 for P01/2), and 12 mo (n 5 4 for P01/1 and P01/2). Note elevated number of macrophages in quadriceps nerves of 6- and
12-mo-old P01/2 mice. A slight elevation of macrophage numbers is already seen in quadriceps nerves of 2-mo-old P01/2 mice. In non-
demyelinating saphenous nerves, the number of macrophages is not increased at any age investigated. Bars represent mean values 6 SD.
*P , 0.05; ***P , 0.001. Bar, 50 mm.
Figure 2. Cellular localization of the M-CSF re-
ceptor (MCSFR, red) immunoreactivity in
teased fiber preparations from ventral roots of
P01/1 and P01/2 mice using antibodies to aMb2
integrin (green) as a marker for peripheral nerve
macrophages. aMb2-negative cells, such as the
adjacent Schwann cells, were never labeled.
Note the particularly strongly MCSFR-immu-
noreactive macrophage in the P01/2 mutant (ar-
row). Bar, 50 mm.The Journal of Cell Biology, Volume 152, 2001 304
We quantified the macrophages in muscular and cutane-
ous branches of the femoral nerve and in spinal roots of
P01/1 and P01/2 mice by immunohistochemistry using the
F4/80 antibody. In the quadriceps muscle nerves of the P01/1
mice,  approximately five F4/80-positive macrophages per
nerve section were found at 2, 6, and 12 mo (Fig. 1 C). In
contrast to the normal wild-type mice, the number of mac-
rophages in the quadriceps nerve of heterozygous P01/2
mice was slightly elevated at 2 mo, increased z3.5-fold at 6
mo, and 5-fold at 12 mo of age (P , 0.001; Fig. 1 C).
Macrophage counts in the cutaneous saphenous nerve
of P01/1 mice revealed a similar number as that in the nor-
mal, wild-type quadriceps nerves at any age investigated
(Fig. 1 C). The number of macrophages in the P01/2
saphenous nerves was normal and did not show an age-
dependent increase, a finding in line with the still unex-
plained lack of demyelinating neuropathy in the sensory
nerves of P01/2 mice (Martini et al., 1995; Shy et al., 1997)
and of some other myelin mutants (Martini, 1997). This di-
vergence between muscular and cutaneous nerves in the
Figure 3. Conventional electron microscopy (A and B) and immunoelectron microscopy using the macrophage-specific antibody F4/80
(C and D) in quadriceps nerves of 6-mo-old P01/2 mice. (A) A putative macrophage (m) that is laden with myelin debris is closely ap-
posed to a demyelinated axon (a). Note the slender processes of the macrophage (arrows) and the position of the cell within the endo-
neurial tube. The arrowheads demarcate the Schwann cell basal lamina. (B) A putative macrophage (m) is in close contact to a thin my-
elin sheath that is partially detached from the corresponding axon (a). The arrow demarcates a process of the putative macrophage that
penetrates the Schwann cell basal lamina. Sc, Schwann cell. (C) An F4/80-positive macrophage (m) containing myelin debris is in close
apposition to a myelin sheath. Arrowheads indicate electron-dense immunoreaction product. a, Axon; Sc, Schwann cell. (D) A slender
process of a F4/80-positive macrophage (m) has penetrated in between the pericaryon of the Schwann cell (Sc) and its normal appearing
myelin sheath. Arrowheads indicate electron-dense immunoreaction product. a, axon. Bars, 1.5 mm.Carenini et al. Macrophages in Peripheral Nerves of P0-deficient Mice 305
P01/2 animals also extended to spinal roots, with the mac-
rophages consistently more numerous in the ventral roots
than in the dorsal, or in any nerves from the normal, P01/1
mice. In addition to differences in number, the F4/80-
immunoreactive cells in the quadriceps nerves and ventral
roots of P01/2 mice also appeared larger compared with
saphenous nerves and dorsal roots of the same genotype,
or with spinal roots and femoral nerves of P01/1 mice (Fig.
1 B). Some of these macrophages from the P01/2 nerves
were also laden with lipid vacuoles or with material remi-
niscent of myelin debris, a finding that we did not observe
in the P01/1 mice or in the P01/2 sensory nerves.
Conventional Electron Microscopy and 
Immunoelectron Microscopic Localization of 
Macrophages in Peripheral Nerves of P01/2 Mice
To investigate the spatial relationship of macrophages to
demyelinating fibers, we performed conventional electron
microscopy and immunoelectron microscopy with F4/80
antibodies in quadriceps nerves and ventral roots of 6-mo-
old P01/2 mice.
In ultrathin sections of conventionally prepared quadri-
ceps nerves and ventral roots, endoneurial cells laden with
lipid vacuoles or myelin debris were identified as mac-
rophages. They were often found in the endoneurium
and were characterized by polymorphic nuclei, abundant
heterochromatin, and microvillus-like processes that ex-
tended from the surface. Occasionally, such cells were
found in the endoneurial tubes, i.e., within the Schwann
cell basal laminae (Fig. 3, A and B). In very rare cases,
macrophage-like cells were seen just penetrating the basal
lamina with a cellular process, reflecting the invasion or
leave of the endoneurial tube (Fig. 3 B). However, since
Schwann cells can also phagocytose myelin and penetrate
basal laminae under pathological conditions, morphologi-
cal criteria alone appeared insufficient to characterize un-
equivocally the spatial relationship between macrophages
and nerve fibers. Therefore, we performed immunoelec-
tron microscopy using the macrophage-specific antibody
F4/80.
The majority of the F4/80-positive macrophages were
found in the endoneurial space. Approximately 10–30% of
the F4/80-positive cells were found within the endoneurial
tubes, i.e., within the inner aspects of the basal laminae
(Fig. 3, C and D). Occasionally, the macrophages were in
intimate association with myelin sheaths that appeared
morphologically normal (Fig. 3, C and D), suggesting an
active role of macrophages during demyelination. In other
cases, myelin appeared disorganized or was even absent
and the demyelinated axons were in direct contact with
the macrophages (not shown). No immunoreactivity was
observed on axons or on morphologically unequivocally
identified Schwann cells.
P0/op Double Mutants: Fewer Macrophages in Femoral 
Nerves and Less Severe Demyelination
In the current study, we used mice deficient for M-CSF
(op/op) and heterozygous for P0 (P01/2) to investigate the
role of macrophages in genetically caused demyelination.
Myelin mutant littermates with the normal M-CSF pheno-
type (P01/2 op/wt or P01/2 wt/wt) served as controls.
In the quadriceps nerve of M-CSF–deficient, P0 het-
erozygous mice (P01/2  op/op), the number of macro-
phages was not increased compared with mice with normal
P0 dosage (P01/1 op/wt and P01/1 op/op; Fig. 4). In con-
trast, and similar to the findings obtained from P01/2 mice
(Fig. 1 C), the number of macrophages in the quadriceps
nerve was strongly elevated in P01/2 op/wt mice compared
with op mutants with normal P0 gene dosage (P01/1 op/wt
and P01/1 op/op mice; P 5 0.01; Fig. 4). Thus, homozygous
deficiency in M-CSF leads to a lack of an age-dependent
macrophage increase in the motor nerves of P01/2 mu-
tants.
To investigate whether compromised macrophage in-
crease in P01/2 op/op mice has an influence on the number
of T lymphocytes, we also investigated the number of
CD8-positive cells in 6-mo-old P01/1 op/wt, P01/2 op/wt,
and P01/2 op/op mice. Due to the low amount of tissue
available from the limited number of mutants, only sciatic
nerves could be investigated (n 5 3 for each genotype). In
the sciatic nerves of P01/1 op/wt mice, 1.7 60.2 T lympho-
cytes/mm2 could be detected. There was a clear trend to
higher values in P01/2 op/wt mice (2.6 6 0.4 cells/mm2),
but not in the P01/2 op/op mice (1.9 6 0.3 cells/mm2). The
differences between P01/2  op/wt and P01/2  op/op mice
failed to reach statistical significance (P 5 0.06), possibly
due to the previously discussed heterogeneous distribution
of the lymphocytes (Schmid et al., 2000).
Comparison of semithin sections of quadriceps nerves
and ventral roots from 6-mo-old P01/2 op/wt mice with
those from the P01/2 op/op littermates revealed that all
mice with P01/2 genotype showed pathological alterations
indicative of demyelination. However, the severity of the
pathological alterations was clearly reduced in mice with
the op/op genotype. Thus, an investigator who was not
Figure 4. Quantification of F4/80-positive macrophages in quad-
riceps and saphenous nerves of P01/1 op/wt (black bars, n 5 5),
P01/1 op/op (white bars, n 5 3), P01/2 op/wt (dark gray bars, n 5
9), and P01/2 op/op mice (bright gray bars, n 5 3) at the age of 6
mo. The op genotype has no influence on the number of resident
macrophages in quadriceps nerves of P01/1 mice. In quadriceps
nerves of P01/2 op/wt mice, the number of macrophages is simi-
larly increased, as shown in Fig. 1 C, whereas homozygosity for
op prevents the increase of macrophage numbers in quadriceps
nerves of the myelin mutants (P01/2 op/op). In the nondemy-
elinating saphenous nerves, the number of macrophages is never
increased. Bars indicate mean values 6 SD. *P , 0.05.The Journal of Cell Biology, Volume 152, 2001 306
aware of the genotype (R. Martini) could unequivocally
distinguish the nerves from P01/2 op/wt mice from those of
P01/2 op/op mice.
The thickness of myelin was a particularly striking pa-
rameter in the presence or absence of M-CSF. Motor
nerves from P01/2 op/op mice always had thicker myelin
sheaths than those from the P01/2 op/wt littermates. This
difference was strongest in the ventral roots (Fig. 5, A and
B), but substantial differences in myelin thickness between
P01/2 op/wt and P01/2 op/op mice were also obtained for
the quadriceps nerves (not shown). Semithin sections of
quadriceps nerves and ventral roots of P01/1 op/wt and
P01/1 op/op mice were also investigated at the age of 6 mo.
These nerves were of normal phenotype with thick myelin
and absence of features indicative of demyelination inde-
pendent of the op genotype (not shown).
To quantify the less reduced myelin thickness in quadri-
ceps nerves and ventral roots of P01/2 op/op mice versus in
P01/2 op/wt mice, we determined the g-ratio of the myelin
sheaths at the electron microscopic level. In agreement
with the light microscopic findings, the g-ratios were sig-
nificantly lower in quadriceps nerves (0.78 in P01/2 op/op
mice versus 0.82 in P01/2 op/wt mice, P , 0.05, n 5 3). Sim-
ilar differences in g-ratios were found in ventral roots of
P01/2 op/op mice versus P01/2 op/wt mice (Fig. 5), thus re-
flecting thicker myelin in the myelin mutants with compro-
mised macrophage function. Analysis of g-ratios of smaller
(,6 mm) and larger (.6 mm) caliber fibers of ventral roots
revealed that in P01/2 op/op mice, the g-ratios of both fi-
ber groups were decreased, representing rescue of myelin
thickness in both smaller and larger caliber fibers (P ,
0.05 for both size groups; Fig. 5, A and B). Although in
P01/2 op/op mice myelin thickness was clearly increased
compared with P01/2 op/wt mice, normal myelin thickness
was not reached as reflected by a lower g-ratio in ventral
roots of P01/1 mice (Fig. 5 C).
Discussion
This study focused on the functional roles of macrophages
in an established animal model for CMT1B, the P0 het-
erozygous mice. We found that the number of macro-
phages was strongly increased and that they showed a fre-
quent association with demyelinating fibers. When the
P01/2 mice were crossbred with spontaneous mouse mu-
tants deficient in M-CSF, the resulting double mutants
lacked the increase in number of macrophages and showed
less severe pathological alterations. Our findings show that
macrophages are actively involved in demyelination in a
model for inherited neuropathies.
Functional Role of Macrophages in P01/2 Mice
Previous studies in M-CSF–deficient (op/op) mice re-
vealed an impaired survival, development, and differentia-
tion of the monocyte hematopoietic cell lineage in the
absence of M-CSF (Felix et al., 1990; Metcalf, 1991; Wit-
mer-Pack et al., 1993; Stanley et al., 1997; for review see
Teitelbaum, 2000). In the central nervous system of the
Figure 5. (A and B) Electron
microscopy of ventral roots of
6-mo-old P01/2 op/wt (A) and
P01/2 op/op mice (B). Myelin
thickness in P01/2 op/wt mice
is profoundly reduced com-
pared with P01/2 op/op litter-
mates. Note that in P01/2 op/
wt mice (A) both small (aster-
isk) and large caliber fibers
(double asterisk) are associ-
ated with abnormally thin my-
elin. The presence of fibers
with thicker and thinner my-
elin in one and the same sec-
tion in A represents segmental
demyelination as has been de-
scribed previously in longitu-
dinal views of teased fibers
(Martini et al., 1995). (C)
Quantitative analysis of
g-ratios of myelinated fibers
in ventral roots of P01/2 op/wt
(dark gray bars, n 5 3), P01/2
op/op (bright gray bars, n  5
3), and P01/1 mice (black bars,
n  5  3) at the age of six
months. Note the reduction in
g-ratios in roots from P01/2
op/op mice reflecting thicker
myelin sheaths, when com-
pared with values from P01/2
op/wt mice. *P , 0.05. P01/1
mice display the thickest my-
elin sheaths. Bars, 5 mm.Carenini et al. Macrophages in Peripheral Nerves of P0-deficient Mice 307
op/op mice, microglial activation is severely impaired un-
der various pathological conditions (Raivich et al., 1994;
Berezovskaya et al., 1995). In the peripheral nervous sys-
tem of the osteopetrotic P01/1 mice, the number of resi-
dent macrophages was normal. However, the number of
macrophages did not increase in the myelin-deficient os-
teopetrotic double mutants, which is reminiscent of find-
ings in the injured central nervous system of osteopetrotic
single mutants (Raivich et al., 1994). This lack of macro-
phage reaction upon the diseased peripheral nervous tis-
sue in op/op mice must be considered to be due to a direct
and exclusive impairment of the macrophage response,
since we show that in P01/2 mice M-CSF receptor was ex-
clusively found on macrophages, a situation similar to the
normal and injured central nervous system (Raivich et al.,
1998). Thus, our combined findings not only demonstrate
that macrophages are pivotal cellular mediators of myelin
damage in this primarily genetically caused demyelinating
neuropathy, but also that M-CSF is a critical molecule for
the activation of these myelin-phagocytosing cells.
Macrophages play important roles under several patho-
logical conditions, including inflammatory disorders of the
nervous system (Hartung et al., 1998; Ho et al., 1998;
Kiefer et al., 1998; Gold et al., 1999). In the peripheral ner-
vous system, these functions are particularly well charac-
terized in experimental autoimmune neuritis, the animal
model for the Guillain-Barré syndrome. In this disease,
macrophages present antigen to autoimmune lymphocytes
in the context of MHC class II, which results in activation
and proliferation of T lymphocytes (Hartung et al., 1998;
Gold et al., 1999). Interestingly, in P01/2 mice the previ-
ously reported increase of the number of T lymphocytes
(Schmid et al., 2000) appears to be lacking when macro-
phage activation is compromised due to the absence of
M-CSF. Since T lymphocytes do not carry M-CSF recep-
tors (Raivich et al., 1998), one has to postulate that the
reduced number of antigen-presenting and/or cytokine-
secreting macrophages might be the reason for the accom-
panying lack of increase of T lymphocytes.
Macrophages are also involved in the effector phase of
the disorders (Craggs et al., 1984; Jung et al., 1993; Har-
tung et al., 1998; Gold et al., 1999). In electron microscopy
studies of Guillain-Barré syndrome and experimental au-
toimmune neuritis, activated macrophages are seen in
direct contact with myelin (Ballin and Thomas, 1969;
Lampert, 1969; Ho et al., 1998; Smith, 1999) which is simi-
lar to the macrophage–myelin apposition in our animal
model for inherited neuropathies. Apart from the direct
physical attack, macrophages also synthesize numerous
factors, such as arachidonic acid metabolites, oxygen radi-
cals, nitrous oxide, matrix metalloproteinases, and proin-
flammatory cytokines that can all act to jeopardize myelin
stability and the normal function of the myelin-forming
Schwann cell (Banati et al., 1993; Ho et al., 1998; Gold et
al., 1999).
The Role of Macrophages in Human
Inherited Neuropathies
Similar to our animal model, an increased number of en-
doneurial macrophages has also been reported in nerve bi-
opsies of patients with inherited peripheral neuropathies
(Sommer and Schröder, 1995; Schmidt et al., 1996; Stoll et
al., 1998). In many forms of CMT the active phase of de-
myelination occurs during childhood (Gabreëls-Festen et
al., 1995; Garcia et al., 1998; Thomas, 1999), and nerve bi-
opsies were usually not performed. It is conceivable that
circulating monocytes enter the peripheral nerve to clear
the myelin debris that results from genetically mediated
disintegration of myelin. However, macrophages may also
actively help to destroy the myelin produced by the mu-
tant Schwann cells. This notion is clearly supported by the
data of the current study in P0 mutant mice, as was sug-
gested previously by noting the close association of mac-
rophages with the myelin at the ultrastructural level of in-
herited human neuropathy (Vital et al., 1992).
What are the possible implications of the current findings
for our understanding of human inherited neuropathies?
Only few inherited neuropathies are caused by an abnor-
mal gene dosage of P0 (Nelis et al., 1999), but this does not
argue against the possibility that similar mechanisms can
take place in demyelinating CMT forms that are unrelated
to P0 mutations. Indeed, a similar elevation of macrophage
numbers as seen in P01/2 mice has recently been found in
Cx32-deficient mice (Kobsar, I., M. Mäurer, and R. Mar-
tini, unpublished observations), a model for the X-linked
form of CMT (Anzini et al., 1997; Scherer et al., 1998).
Most interestingly, in some patients with CMT a rather
rapid worsening or even overt inflammation (Gregory et
al., 1993; Malandrini et al., 1999) with clinical response to
corticosteroid treatment (Bird and Slaky, 1991; Crawford
and Griffin, 1991; Dyck et al., 1982) or plasma exchange
(Malandrini et al., 1999) has been described. It is possible
that these clinical cases are at the extreme end of an immu-
nopathologic and chronic disease process that may be un-
noticed in the majority of cases. Future studies in the
mouse models as well as in human biopsies using appropri-
ate macrophage markers (Kiefer et al., 1998) are needed to
substantiate our conclusions with the aim to develop treat-
ment strategies that culminate in the impairment of the det-
rimental immune cells in peripheral nerves of patients.
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